TriSalus Life Sciences (TLSI) EPS (Basic) Growth (3y) (2024 - 2026)
TriSalus Life Sciences (TLSI) EPS (Basic) Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.37 Bn | 195.76 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 126.27 Bn | 122.79 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 118.65 Bn | 109.43 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.77 Bn | 47.51 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.62 Bn | 32.68 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.70 Bn | 31.59 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.13 Bn | 22.65 Bn | 684.20 Mn | 17.98% |
| 10 | TriSalus Life Sciences | 304.31 Mn | 258.02 Mn | 9.90 Mn | 61.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.11% |
| Mar 31, 2026 | 26.42% |
| Dec 31, 2025 | 38.12% |
| Sep 30, 2025 | -43.60% |
| Jun 30, 2025 | -77.40% |
| Mar 31, 2025 | -84.51% |
| Dec 31, 2024 | -170.38% |
| Sep 30, 2024 | -116.15% |
| Jun 30, 2024 | -317.65% |
| Mar 31, 2024 | -269.50% |